Rejuvenate Bio
Develops gene therapies for age-related and chronic diseases in animals and humans
$6MStrategic
Role not disclosedKC
Kendall Capital Partners
Activity from announced rounds
Activity in this selectionjoaquin-quinonero-candela-1ce1da45
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $43M 2 disclosed · full round size, not this investor’s share